COVID-19 (SARS-CoV-2) in Urine and Semen

NCT04446169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2021-10-11

No results posted yet for this study

Summary

This study is part of the current global emergency scenario due to infection with Coronavirus, SARS-CoV-2 as indicated by the international taxonomy. Study aim is to investigate the possibility of the presence of the virus within the seminal fluid and in the urine of infected patients, both during the acute phase and remotely. Current evidences show that Coronaviruses can be present inside the testicle and sperm in other species, such as in feline and avian models.

In human beings, current researches have mixed results regarding the presence of SARSCoV-2 in urine, as several studies with a large sample found no traces of the same with Real-Time Reverse method Transcriptase - Polymerase Chain Reaction or with method of nucleic acid amplification. By contrast, in just over 6% of 58 patients with Real Time Polymerase Chain Reaction method have found the presence of SARS-CoV-2 in the urine, even at a distance from the last negative nasopharyngeal swab.

Given the topicality of the problem, our study has the objective of specifically researching the presence and possible persistence over time of SARS-CoV-2 in seminal fluid and urine.

A saliva sample will also be collected as a control. At the moment there are no studies in literature that tested this possibility. If confirmed, it would lead to find out another potential method of transmission, the sexual one, in asymptomatic patients or apparently no longer infectious with negative buffer. The rationale for our study is the evidence that in other species this type of transmission by coronaviruses is possible and that at present it has not been verified in mankind.

The relevance of the study would be both in the case of a negative result, as the first study in its generally, both in the case of a positive result, due to the possibility of introducing new prevention measures in the long run.

Conditions

  • SARS-CoV 2
  • Sexual Function and Fertility Disorders
  • Urinary Function Disorders
  • Urine
  • Semen

Interventions

DIAGNOSTIC_TEST

SARS-CoV 2 RNA PCR Urine

Search for SARS-CoV 2 RNA in urine through PCR

DIAGNOSTIC_TEST

SARS-CoV 2 RNA PCR Semen

Search for SARS-CoV 2 RNA in Semen through PCR

DIAGNOSTIC_TEST

Semen Qualitative Analysis

Search for Semen Alterations in patients with past SARS-CoV 2 infection

DIAGNOSTIC_TEST

IIEF-5 questionnaire

IIEF-5 assessment in patients with past SARS-CoV 2 infection

DIAGNOSTIC_TEST

Male Sexual Health Questionnaire (MSHQ)

Male Sexual Health Questionnaire (MSHQ) assessment in patients with past SARS-CoV 2 infection

DIAGNOSTIC_TEST

IPSS questionnaire

IPSS assessment in patients with past SARS-CoV 2 infection

DIAGNOSTIC_TEST

SECRET questionnaire

SECRET questionnaire assessment in patients with past SARS-CoV 2 infection

DIAGNOSTIC_TEST

Interleukin assessment in semen

Assessment of Interleukin presence and quantitative analysis in semen, to study if a previous inflammation/infection due to SARS-CoV 2 in testis was present

Sponsors & Collaborators

  • Azienda Ospedaliero-Universitaria Careggi

    collaborator OTHER
  • University of Florence

    lead OTHER

Principal Investigators

  • Mauro Gacci, MD · Careggi University Hospital

  • Sergio Serni, Prof · University of Florence

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-27
Primary Completion
2020-09-01
Completion
2021-09-02

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04446169 on ClinicalTrials.gov